# FDA Inspection 907952 - Egis Pharmaceuticals PLC - Kormend Branch - December 18, 2014

Source: https://www.keypedia.com/records/fda_inspections/egis-pharmaceuticals-plc-kormend-branch/5757c99c-725d-4fb6-8c57-d527f3eeb30b
Source feed: FDA_Inspections

> FDA Inspection 907952 for Egis Pharmaceuticals PLC - Kormend Branch on December 18, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 907952
- Company Name: Egis Pharmaceuticals PLC - Kormend Branch
- Inspection Date: 2014-12-18
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 707730 - 2011-01-28](https://www.keypedia.com/records/fda_inspections/egis-pharmaceuticals-plc-kormend-branch/274a033d-15ae-44b8-9f12-740053dc3414)

Company: https://www.keypedia.com/companies/egis-pharmaceuticals-plc-kormend-branch/2fa28954-1dd8-4059-ab70-f6a6a6ac0b10

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c